Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.

导出 OA

翻译打印收藏纠错

第一作者： P C D,Bank

第一单位： Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.

作者： P C D,Bank ^[1] ; K E,Caudle ^[2] ; J J,Swen ^[1] ; R S,Gammal ^[2] ; M,Whirl-Carrillo ^[3] ; T E,Klein ^[4] ; M V,Relling ^[4] ; H-J,Guchelaar ^[2]

作者单位： Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands. ^[1] Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, Tennessee, USA. ^[2] Department of Pharmacy Practice, MCPHS University, Boston, Massachusetts, USA. ^[3] Pharmacogenomics Knowledgebase (PharmGKB), Stanford University School of Medicine, Palo Alto, California, USA. ^[4]

主题词基因检测(Genetic Testing);人类(Humans);荷兰(Netherlands);遗传药理学(Pharmacogenetics);诊疗准则(主题)(Practice Guidelines as Topic);美国(United States)

DOI 10.1002/cpt.762

PMID 28994452

发布时间 2022-04-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交